Clinical Trial

Multiple Myeloma Extramedulary Disease Samples FFPE

Study acronym: MMExFFPE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to evaluate the feasibility of assembling a retrospective cohort of formalin-fixed paraffin-embedded (FFPE) tissue samples from patients with extramedullary multiple myeloma, together with their associated clinical and pathological data. The study will determine whether these archived samples are suitable for exploratory biomarker assessment. No intervention is performed. All FFPE samples and clinical data originate exclusively from routine diagnostic procedures and will be analyzed retrospectively for research purposes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-15.
Trial Details
NCT Number NCT07354555
Lead Sponsor BIWAKO
Conditions Multiple Myeloma Survival Outcome, Multiple Myeloma and Malignant Plasma Cell Neoplasms
Enrollment 15 participants
Start Date 2026-06-05
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20